Moreover, recently it has been shown that BRAF mutation in papillary thyroid cancer is associated with a more aggressive phenotype and less differentiated state due to decreased expression of iodide-metabolizing [6] and sodium iodide symporter genes [7]. The gene discussed is SLC5A5; the disease is thyroid gland papillary carcinoma.